Literature DB >> 9153644

Inhibition of glutamate decarboxylase activity by 3-mercaptopropionic acid has different time course in the immature and adult rat brains.

M Netopilová1, J Drsata, R Haugvicová, H Kubová, P Mares.   

Abstract

It has been found that the latency of epileptic seizures caused by glutamate decarboxylase (GAD) inhibitor 3-mercaptopropionate (3-MPA) is markedly longer in immature rats than in the adults. Time course of rat brain GAD inhibition was studied in 12-day-old and adult (90-day-old) animals following 3-MPA (70 mg/kg i.p.). GAD activity was determined by quantification of 14CO2 liberated from [1-(14)C]glutamate by supernatant 20,000 x g of brain homogenate prepared from rats killed at different intervals after 3-MPA administration. In adult rats, the enzyme activity decreased significantly by 14.1% even 1 min after 3-MPA administration and was decreasing gradually till the onset of seizures. In immature rats, GAD activity decrease after 1 min was by 41.4% and further decrease was smaller. Comparison of the time profiles of GAD changes in both groups confirmed our findings that in spite of delayed seizure onset, GAD inhibition in immature rats is more pronounced, probably due to immaturity of the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153644     DOI: 10.1016/s0304-3940(97)00241-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Thirty years beyond discovery--clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism.

Authors:  Kara R Vogel; Phillip L Pearl; William H Theodore; Robert C McCarter; Cornelis Jakobs; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2012-06-28       Impact factor: 4.982

2.  Influence of convulsants on rat brain activities of alanine aminotransferase and aspartate aminotransferase.

Authors:  M Netopilová; R Haugvicová; H Kubová; J Drsata; P Mares
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

3.  An investigation into the pharmacokinetics of 3-mercaptopropionic acid and development of a steady-state chemical seizure model using in vivo microdialysis and electrophysiological monitoring.

Authors:  Eric W Crick; Ivan Osorio; Naresh C Bhavaraju; Thomas H Linz; Craig E Lunte
Journal:  Epilepsy Res       Date:  2007-03-26       Impact factor: 3.045

4.  Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons.

Authors:  D D Murphy; N B Cole; V Greenberger; M Segal
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

5.  Microperfusion of 3-MPA into the brain augments GABA.

Authors:  Andrew P Mayer; Ivan Osorio; Craig E Lunte
Journal:  Epilepsy Behav       Date:  2013-10-02       Impact factor: 2.937

6.  Blockade of GABA synthesis only affects neural excitability under activated conditions in rat hippocampal slices.

Authors:  Nese Dericioglu; Cheryl L Garganta; Ognen A Petroff; Dara Mendelsohn; Anne Williamson
Journal:  Neurochem Int       Date:  2008-04-22       Impact factor: 3.921

7.  Maintenance of thalamic epileptiform activity depends on the astrocytic glutamate-glutamine cycle.

Authors:  Astra S Bryant; Bojia Li; Mark P Beenhakker; John R Huguenard
Journal:  J Neurophysiol       Date:  2009-09-09       Impact factor: 2.714

8.  Exogenous γ-aminobutyric acid (GABA) affects pollen tube growth via modulating putative Ca2+-permeable membrane channels and is coupled to negative regulation on glutamate decarboxylase.

Authors:  Guang-Hui Yu; Jie Zou; Jing Feng; Xiong-Bo Peng; Ju-You Wu; Ying-Liang Wu; Ravishankar Palanivelu; Meng-Xiang Sun
Journal:  J Exp Bot       Date:  2014-05-05       Impact factor: 6.992

9.  Monoterpenoid terpinen-4-ol exhibits anticonvulsant activity in behavioural and electrophysiological studies.

Authors:  Franklin F F Nóbrega; Mirian G S S Salvadori; Cintia J Masson; Carlos F Mello; Tiago S Nascimento; José H Leal-Cardoso; Damião P de Sousa; Reinaldo N Almeida
Journal:  Oxid Med Cell Longev       Date:  2014-08-10       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.